Tag: Atrial Fibrillation
Updates on anti-arrhythmic agents
Sex differences revealed in AF determinants and AF progression
Early rhythm-control therapy efficacious in men and women with AF
Progression in remote app-based monitoring of atrial fibrillation
Low AF recurrence rates after PVI using pulsed-field ablation
Ultrasound-guided femoral venipuncture reduces complications in catheter ablation
Focus on the efficacy of cardiac resynchronisation therapy in HF plus concomitant AF
Insertable cardiac monitors effective for AF detection in cryptogenic stroke
Developments in imaging tools for AF
Large impact of remote screening tool on sleep apnoea diagnoses in AF
Ibrutinib continues to outperform chemoimmunotherapy in patients with treatment-naïve CLL
New developments in remote diagnostics and monitoring of AF
Head-to-head: Efficacy of dabigatran versus warfarin on cognitive impairment
Posterior left pericardiotomy safe and effective in reducing atrial fibrillation
LAA ligation did not reduce recurrent atrial arrhythmias in persistent AF
Equal benefits of early rhythm control in AF subtypes
2021 ESC/EACTS Guidelines on Valvular Heart Disease
2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy
ESC 2021 Highlights Podcast
Omecamtiv mecarbil might be less effective in patients with atrial fibrillation or flutter
Vericiguat effective irrespective of atrial fibrillation status
COVID-19 in AF patients with HF: no higher mortality but longer hospital stay
Psychoactive substances put young people at risk of cardiovascular disease
Ablation-based rhythm control as effective as rate control in AF and HF
Finerenone reduces the risk of AF onset in patients with CKD and diabetes
EHRA Practical Guide on cardiac imaging in electrophysiology
Early rhythm-control ablation: insight from the CHARISMA registry
Personalised pulmonary vein isolation procedure feasible and effective
Pulmonary vein isolation: cryoballoon non-inferior to radiofrequency ablation
Predictors of young-onset atrial fibrillation
RACE 3 long-term results show fading benefit of targeted therapies in AF and HF
Deep dive into EAST-AFNET 4 results on early rhythm-control in atrial fibrillation
Cryo-FIRST study: improved AF and QoL outcomes with cryoballoon versus drug therapy
STROKESTOP: Benefits of systematic screening for atrial fibrillation
DOACs and bleeding: the role of antidotes
2021 EHRA practical guide: DOACs in pre-operative and bleeding patients
AF monitoring following cardiovascular surgery
Vitamin D or omega 3 fatty acids do not prevent AF
Active screening for AF improves clinical outcomes
AF screening in older adults at primary care visits
Unfavourable outcomes for COVID-19 patients with AF and atrial flutter
2020 Atrial Fibrillation Guidelines
Reduced cardiovascular outcomes with early rhythm control
Drug initiation strategy not associated with increased use of oral anticoagulants
Digoxin improves symptoms in stable patients with permanent AF
Early edoxaban may be safe after cardioembolic stroke
Surgical bleeding risk most important determinant of bleeding outcomes
Similar bleeding rates in patients with VTE and AF treated with DOACs
Factor V Leiden mutation linked to atrial fibrillation
LAAO Watchman registry data positive
Finding the sweet spot of anticoagulation in AF patients with ACS
Apixaban in AF patients with recent ACS/PCI: Drop aspirin after 30 days
Infusion of ethanol in the vein of Marshall for persistent AF
Aspirin plus DOAC is not better than a DOAC alone
RENAL-AF trial: Apixaban similar to warfarin
Apple Heart Study: Not just for atrial fibrillation
Early apixaban safe as secondary prevention of stroke from AF
Similar rates of stroke/SE associated with DOAC vs warfarin use in obese non-valvular AF patients: Results from an observational registry
Substantial impact of temporary interruptions of warfarin versus DOAC
